PM

Professor Mattick

Professor Mattick was Chief Executive of Genomics England, which was established by the United Kingdom government to foster the use of genetic information in healthcare. He was Director of the Garvan Institute of Medical Research in Sydney from 2012 to 2018, where he established high throughput NATA accredited DNA sequencing and genome analysis facilities. He was a member of the Australian Health Ethics Committee (AHEC) of the National Health & Medical Research Council (NHMRC) from 1997 to 2003, an advisor to the Australian Law Reform Commissions Inquiry into the Protection of Human Genetic Information and Gene Patenting & Human Health, and the AHEC Committee to Revise the Ethical Guidelines on Assisted Reproductive Technology. He was appointed an Officer of the Order of Australia in 2001 for services to scientific research in the fields of molecular biology, genetics and biotechnology. He is a member of the Risk Management Committees.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
27/08/254,136250,181N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
27/08/25
Buy
200,000$0.910$182,000On-market trade
14/05/24
Transfer
15,093$1.340$20,224As advised by the company
14/05/24
Transfer
15,093$1.340$20,224As advised by the company
14/12/23
Issued
4,136$1.200$4,963Rights issue
14/12/23
Issued
7,546$1.200$9,055Rights issue